Pharming Group N.V.
$9.36
-0.27 (-2.80%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -13.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -24.2%
Own PHAR?
See how PHAR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.